找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Data Monitoring in Clinical Trials; A Case Studies Appro David L. DeMets,Curt D. Furberg,Lawrence M. Friedm Book 2006 Springer-Verlag New Y

[复制链接]
楼主: hexagon
发表于 2025-3-28 18:14:18 | 显示全部楼层
Early Termination of the Diabetes Control and Complications Trialy caused these complications. The study was terminated one year ahead of schedule by the monitoring board. This paper describes the medical, ethical, and statistical challenges faced by the study group and the monitoring board.
发表于 2025-3-28 21:12:22 | 显示全部楼层
The Essentials of Nursing Management Seriese study not being double-blind) in the medical management of patients or in the diagnosis of events; and (5) evaluate treatment effects in subgroups of the study participants. Experiences from the Coronary Drug Project in making decisions for early termination and for non-termination of treatment groups are described.
发表于 2025-3-29 01:40:43 | 显示全部楼层
Communication with Young Peoplenated after 20 months, before its scheduled completion, based on an observed adverse effect of milrinone on survival. This paper describes the experience of the Data Monitoring and Safety Monitoring Board (DSMB) in dealing with an emerging negative trend in survival when there were other known beneficial effects of the drug.
发表于 2025-3-29 05:26:38 | 显示全部楼层
Breaking New Ground: Data Monitoring in the Coronary Drug Projecte study not being double-blind) in the medical management of patients or in the diagnosis of events; and (5) evaluate treatment effects in subgroups of the study participants. Experiences from the Coronary Drug Project in making decisions for early termination and for non-termination of treatment groups are described.
发表于 2025-3-29 10:45:07 | 显示全部楼层
Data Monitoring in the Prospective Randomized Milrinone Survival Evaluation: Dealing With an Agonizinated after 20 months, before its scheduled completion, based on an observed adverse effect of milrinone on survival. This paper describes the experience of the Data Monitoring and Safety Monitoring Board (DSMB) in dealing with an emerging negative trend in survival when there were other known beneficial effects of the drug.
发表于 2025-3-29 12:25:26 | 显示全部楼层
发表于 2025-3-29 19:21:37 | 显示全部楼层
发表于 2025-3-29 21:06:35 | 显示全部楼层
Protocol Specification and Designy caused these complications. The study was terminated one year ahead of schedule by the monitoring board. This paper describes the medical, ethical, and statistical challenges faced by the study group and the monitoring board.
发表于 2025-3-30 02:59:20 | 显示全部楼层
发表于 2025-3-30 04:49:47 | 显示全部楼层
Communication Protocol Performancel event. Several additional factors were involved, including little or no trend in either CVD mortality or stroke, although the numbers of events were too low to distinguish between small benefit, no effect, and small harm. These circumstances suggested clear evidence for aspirin in preventing a fir
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-17 03:09
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表